Mefitel film for radiation dermatitis: it works, why not?

Published Date: 13 Mar 2023

According to the results of a phase 3 trial, the use of silicone film before radiotherapy can reduce the incidence of radiodermatitis, so why not use it?

Read Full News

Latest News

AstraZeneca Suffers Another Setback as It Halts Volrustomig Lung Cancer Trial

AstraZeneca said it is ending a late-stage trial that combined one of its key experimental drugs with chemotherapy to treat a certain type of lung cancer, extending a ⁠run...

Nestle Looks to Develop New Products to Serve Users Of Weight-loss Drugs

Nestle is seeking to turn the rise of GLP-1 weight-loss drugs from a threat into a business opportunity, using artificial intelligence and nutritional science to develop...

US Kindergarten Vaccine Coverage Continues Downward Trend, Falling 0.1%

U.S. kindergarten vaccination coverage fell 0.1% during the 2025-2026 school year, continuing a downward trend that has seen declines every year except one since the onset...

‘Squishy’ Toy Warning After Children Suffer Serious Burns

Burn specialists report serious injuries after children heat gel-filled toys, prompting authorities to warn families against microwaving them or using them improperly.

Topical Finasteride Effective for Hair Loss in Men

Topical finasteride 0.25% monotherapy demonstrates sustained effectiveness and a favourable safety profile in men with androgenetic alopecia over 52 weeks.

Povorcitinib Beneficial for HS in Phase 3 Studies

According to new phase 3 trial results, povorcitinib, a JAK1 inhibitor, could provide an oral alternative to injectable biologics for patients with hidradenitis suppurativa.

Todays Updates

NPM1-Mutated AML: Not All Treatments Are Equal

Researchers conducted a retrospective analysis of patients with newly diagnosed NPM1-mutated AML treated with high- or low-intensity regimens.

Transgender Individuals Prefer HPV Self-Swabs

Transgender and gender-diverse individuals prefer self-collected HPV testing for cervical cancer screening, a new survey shows.

Todays Updates

NPM1-Mutated AML: Not All Treatments Are Equal

Researchers conducted a retrospective analysis of patients with newly diagnosed NPM1-mutated AML treated with high- or low-intensity regimens.

Transgender Individuals Prefer HPV Self-Swabs

Transgender and gender-diverse individuals prefer self-collected HPV testing for cervical cancer screening, a new survey shows.

Latest News

AstraZeneca said it is ending a late-stage trial that combined one of its key experimental drugs with chemotherapy to treat a certain type of lung cancer, extending a ⁠run...

Nestle is seeking to turn the rise of GLP-1 weight-loss drugs from a threat into a business opportunity, using artificial intelligence and nutritional science to develop...

U.S. kindergarten vaccination coverage fell 0.1% during the 2025-2026 school year, continuing a downward trend that has seen declines every year except one since the onset...

Burn specialists report serious injuries after children heat gel-filled toys, prompting authorities to warn families against microwaving them or using them improperly.

Topical finasteride 0.25% monotherapy demonstrates sustained effectiveness and a favourable safety profile in men with androgenetic alopecia over 52 weeks.

According to new phase 3 trial results, povorcitinib, a JAK1 inhibitor, could provide an oral alternative to injectable biologics for patients with hidradenitis suppurativa.

News All Time

Hyperinsulinemic Hypoglycemia: Looking Beyond Insulinoma?

A distinctive metabolic signature may identify rare insulin receptor disorders earlier, helping clinicians avoid unnecessary insulinoma investigations.

FDA Approves Replimune Skin Cancer Drug After Rejections

The accelerated approval follows FDA concerns about the single-arm evidence supporting the treatment.

TikTok Turns Isotretinoin Into a Beauty Trend

Social media has fueled new demand for isotretinoin, but the drug’s true value and its best-known risks remain defined by evidence, not influencer hype.

Manufacturer Files for Botox Approval for Jawline Contouring

After positive findings from phase 3 trials, Allergan Aesthetics submits sBLA to the FDA for onabotulinumtoxinA, to improve the appearance of the masseter muscle.

Combo Therapy May Clear Stubborn Warts Faster

Combining topical urea with carboxytherapy may help reduce lesion size more effectively and achieve faster clearance than urea alone in patients with treatment-resistant common warts.

Deucravacitinib Shows Sustained Efficacy and Safety in PsA

Deucravacitinib shows greater efficacy than placebo in adults with active psoriatic arthritis at week 16, with sustained benefits through week 52 and a well-tolerated safety profile.

CSCC Incidence, NMSC Mortality Rise in England

The incidence of keratinocyte cancer rose in England from 2013 to 2022, with a stabilising incidence of BCC, an increasing incidence of cutaneous squamous cell carcinoma, and rising NMSC mortality.

Surgeons Warn of 'Regulatory Gap' in Cosmetic Surgery

Surgical royal colleges warn the government's delayed consultation leaves patients exposed to under-qualified practitioners.

Methotrexate Continuation in Psoriatic Disease Differs by Sex

Dutch data highlight the importance of considering sex-specific differences in methotrexate drug survival when prescribing it to patients with psoriatic disease.

Lactate: An Alternative to pH in Fetal Blood Sampling?

Lactate and pH in fetal scalp blood samples show moderate inverse correlation, with a proposed lactate cutoff of ≥ 5.6 mmol/L demonstrating an optimal sensitivity-specificity balance.

Precursor Keratinocyte Lesions Increased in SLE

Patients with systemic lupus erythematosus have higher risks for actinic keratosis and squamous cell carcinoma in situ, in a patient registry analysis.

Two Studies Evaluate RF Microneedling Adverse Event Reports

Fat loss is an often-reported complication following radiofrequency microneedling, two new studies show. But experts are pushing back on both the findings and a recent FDA warning.

Tirzepatide Enhances Outcomes in Obesity With PsA

Patients with obesity and PsA starting tirzepatide alongside biologic therapy reported significantly better symptom control and functional status than those on biologics alone.

Reassurance Not Recommended for Teens With Skin-Focused BDD

Teenagers with skin-related body dysmorphia seeing a dermatologist are not typically helped and might be harmed by simple reassurances that do not address the root problem, an expert maintains.

Smallpox DNA Is Recovered From Spanish Conquest-era Chilean Mummies

When Spanish conquistadors arrived in the New World some five centuries ago, they brought muskets, cannons, armor, horses and attack dogs as they set about colonizing the...

FDA Advisory Panel Backs Replimune's Melanoma Drug

If the agency approves RP1, it would be a major reversal as it has twice rejected the combination drug for advanced melanoma.

Recommended News For You

Despite reports of hundreds of cancer cases, carcinogens have been discovered at nuclear missile sites in Montana.

Immunotherapy after surgery is good for patients with advanced cancer

Researchers identify a novel biomarker linked to renal cancer recurrence

Metastatic Cancer 'Thrivers'; Celebrity Cancer Diagnoses; 'Would He Have Lived?'

Prior authorizations draining time, energy from many cancer patients

Mosunetuzumab in Follicular Lymphoma: Durable Responses and Manageable Safety

Analysis of projected cancer rates in Canada by 2024.

Recommended Articles For You

Liquid Biopsy in Oncology: Innovations in Cancer Detection, Monitoring, and Clinical Use 

Exploring Innovative Approaches to Esophageal Cancer Treatment 

Survival Rate Dynamics in Hematologic and Solid Malignancies 

Navigating the Unknown: A Guide to Living With Hurthle Cell Thyroid Cancer 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Scientists hail the cervical cancer treatment as the most remarkable breakthrough in 20 years.

2.

Axatilimab Demonstrates Effectiveness in Refractory/Recurrent GVHD.

3.

Targeted radiation offers promise in patients with metastasized small cell lung cancer to the brain

4.

'The Pitt' Actor's Cancer Diagnosis; New HHS Research Plans; Madonna Reveals Injury

5.

Benefits of perioperative radiotherapy for liver cancer with a high risk of recurrence are investigated in research.

1.

Next-Gen CAR Cell Therapies in Oncology: Frontiers in Solid Tumors & Hematologic Malignancies

2.

Tumor Ecosystem Activity Biomarkers in Oncology

3.

A Glimmer of Hope: The Predictive Power of Liquid Biopsy and AI in Palliative Oncology

4.

Exploring the Mystery of Angiokeratomas on Scrotum: Causes, Symptoms and Treatment

5.

Iron Chelation Therapy: Preventing Long-Term Treatment Toxicities

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

1.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion

2.

Innovations in Hematology

3.

Current Scenario of Cancer- Q&A Session to Close the Gap

4.

Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias

5.

Blood Clotting Disorders Explained

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot